Cargando…
PB2343: TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB VERSUS STANDARD OF CARE THERAPY IN RELAPSED/REFRACTORY AGGRESSIVE B-CELL NON-HODGKIN LYMPHOMA (OLYMPIA-4)
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429518/ http://dx.doi.org/10.1097/01.HS9.0000976092.30614.25 |
| _version_ | 1785090734936817664 |
|---|---|
| author | Hawkes, Eliza A. Kim, Tae Min Namuduri, Manjusha Risal, Ashish Shen, Biyi Flink, Dina Zhu, Min Nolan, Siobhán Brouwer-Visser, Jurriaan Chaudhry, Aafia Ambati, Srikanth Mohamed, Hesham Cho, Seok-Goo |
| author_facet | Hawkes, Eliza A. Kim, Tae Min Namuduri, Manjusha Risal, Ashish Shen, Biyi Flink, Dina Zhu, Min Nolan, Siobhán Brouwer-Visser, Jurriaan Chaudhry, Aafia Ambati, Srikanth Mohamed, Hesham Cho, Seok-Goo |
| author_sort | Hawkes, Eliza A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429518 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104295182023-08-17 PB2343: TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB VERSUS STANDARD OF CARE THERAPY IN RELAPSED/REFRACTORY AGGRESSIVE B-CELL NON-HODGKIN LYMPHOMA (OLYMPIA-4) Hawkes, Eliza A. Kim, Tae Min Namuduri, Manjusha Risal, Ashish Shen, Biyi Flink, Dina Zhu, Min Nolan, Siobhán Brouwer-Visser, Jurriaan Chaudhry, Aafia Ambati, Srikanth Mohamed, Hesham Cho, Seok-Goo Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429518/ http://dx.doi.org/10.1097/01.HS9.0000976092.30614.25 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Hawkes, Eliza A. Kim, Tae Min Namuduri, Manjusha Risal, Ashish Shen, Biyi Flink, Dina Zhu, Min Nolan, Siobhán Brouwer-Visser, Jurriaan Chaudhry, Aafia Ambati, Srikanth Mohamed, Hesham Cho, Seok-Goo PB2343: TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB VERSUS STANDARD OF CARE THERAPY IN RELAPSED/REFRACTORY AGGRESSIVE B-CELL NON-HODGKIN LYMPHOMA (OLYMPIA-4) |
| title | PB2343: TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB VERSUS STANDARD OF CARE THERAPY IN RELAPSED/REFRACTORY AGGRESSIVE B-CELL NON-HODGKIN LYMPHOMA (OLYMPIA-4) |
| title_full | PB2343: TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB VERSUS STANDARD OF CARE THERAPY IN RELAPSED/REFRACTORY AGGRESSIVE B-CELL NON-HODGKIN LYMPHOMA (OLYMPIA-4) |
| title_fullStr | PB2343: TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB VERSUS STANDARD OF CARE THERAPY IN RELAPSED/REFRACTORY AGGRESSIVE B-CELL NON-HODGKIN LYMPHOMA (OLYMPIA-4) |
| title_full_unstemmed | PB2343: TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB VERSUS STANDARD OF CARE THERAPY IN RELAPSED/REFRACTORY AGGRESSIVE B-CELL NON-HODGKIN LYMPHOMA (OLYMPIA-4) |
| title_short | PB2343: TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB VERSUS STANDARD OF CARE THERAPY IN RELAPSED/REFRACTORY AGGRESSIVE B-CELL NON-HODGKIN LYMPHOMA (OLYMPIA-4) |
| title_sort | pb2343: trial in progress: phase 3 trial evaluating the efficacy and safety of odronextamab versus standard of care therapy in relapsed/refractory aggressive b-cell non-hodgkin lymphoma (olympia-4) |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429518/ http://dx.doi.org/10.1097/01.HS9.0000976092.30614.25 |
| work_keys_str_mv | AT hawkeselizaa pb2343trialinprogressphase3trialevaluatingtheefficacyandsafetyofodronextamabversusstandardofcaretherapyinrelapsedrefractoryaggressivebcellnonhodgkinlymphomaolympia4 AT kimtaemin pb2343trialinprogressphase3trialevaluatingtheefficacyandsafetyofodronextamabversusstandardofcaretherapyinrelapsedrefractoryaggressivebcellnonhodgkinlymphomaolympia4 AT namudurimanjusha pb2343trialinprogressphase3trialevaluatingtheefficacyandsafetyofodronextamabversusstandardofcaretherapyinrelapsedrefractoryaggressivebcellnonhodgkinlymphomaolympia4 AT risalashish pb2343trialinprogressphase3trialevaluatingtheefficacyandsafetyofodronextamabversusstandardofcaretherapyinrelapsedrefractoryaggressivebcellnonhodgkinlymphomaolympia4 AT shenbiyi pb2343trialinprogressphase3trialevaluatingtheefficacyandsafetyofodronextamabversusstandardofcaretherapyinrelapsedrefractoryaggressivebcellnonhodgkinlymphomaolympia4 AT flinkdina pb2343trialinprogressphase3trialevaluatingtheefficacyandsafetyofodronextamabversusstandardofcaretherapyinrelapsedrefractoryaggressivebcellnonhodgkinlymphomaolympia4 AT zhumin pb2343trialinprogressphase3trialevaluatingtheefficacyandsafetyofodronextamabversusstandardofcaretherapyinrelapsedrefractoryaggressivebcellnonhodgkinlymphomaolympia4 AT nolansiobhan pb2343trialinprogressphase3trialevaluatingtheefficacyandsafetyofodronextamabversusstandardofcaretherapyinrelapsedrefractoryaggressivebcellnonhodgkinlymphomaolympia4 AT brouwervisserjurriaan pb2343trialinprogressphase3trialevaluatingtheefficacyandsafetyofodronextamabversusstandardofcaretherapyinrelapsedrefractoryaggressivebcellnonhodgkinlymphomaolympia4 AT chaudhryaafia pb2343trialinprogressphase3trialevaluatingtheefficacyandsafetyofodronextamabversusstandardofcaretherapyinrelapsedrefractoryaggressivebcellnonhodgkinlymphomaolympia4 AT ambatisrikanth pb2343trialinprogressphase3trialevaluatingtheefficacyandsafetyofodronextamabversusstandardofcaretherapyinrelapsedrefractoryaggressivebcellnonhodgkinlymphomaolympia4 AT mohamedhesham pb2343trialinprogressphase3trialevaluatingtheefficacyandsafetyofodronextamabversusstandardofcaretherapyinrelapsedrefractoryaggressivebcellnonhodgkinlymphomaolympia4 AT choseokgoo pb2343trialinprogressphase3trialevaluatingtheefficacyandsafetyofodronextamabversusstandardofcaretherapyinrelapsedrefractoryaggressivebcellnonhodgkinlymphomaolympia4 |